AKT1 and breast carcinoma: Western blotting data (Figure 4) with Akt specific antibody indicate inhibition of Akt phosphorylation with 50 μM (10.17 ± 7.89; P < .05) biochanin A treatment in SK-BR-3 breast cancer cells.